Fibroblast differentiation into myofibroblasts is a key event during normal wound repair. We have previously demonstrated an age-related defect in this process associated with impaired synthesis of hyaluronan (HA) synthase (HAS) 2 but failed to prescribe its role in a mechanistic sense. Here we demonstrate that in addition to HAS2 , there is loss of EGF receptor (EGF-R) in aged cells , and both are required for normal fibroblast functionality. Analysis of molecular events revealed that in young cells , transforming growth factor (TGF)-1-dependent phenotypic activation uses two distinct but cooperating pathways that involve TGF- receptor/Smad2 activation and EGFmediated EGF-R/extracellular signal-regulated kinase (ERK) 1/2 signaling , and the latter is compromised with in vitro aging. Pharmacological inhibition of any of the five intermediates (TGF- receptor , Smad2, EGF , EGF-R , and ERK1/2) attenuated TGF-1 induction of ␣-smooth muscle actin. We present evidence that the HA receptor CD44 co-immunoprecipitates with EGF-R after activation by TGF-1. This interaction is HA-dependent because disruption of HA synthesis abrogates this association and inhibits subsequent ERK1/2 signaling. In aged fibroblasts , this association is lost with resultant suppression of ERK1/2 activation. Forced overexpression of EGF-R and HAS2 in aged cells restored TGF-1-mediated HA-CD44/EGF-R association and ␣-smooth muscle actin induction. Taken together , these results demonstrate that HA can serve as a signal integrator by facilitating TGF-1-mediated CD44-EGF-R-ERK interactions and ultimately fibroblast phenotype. We propose a model to explain this novel mechanism and the functional consequence of age-dependent dysregulation.